275 related articles for article (PubMed ID: 18383370)
1. Beta2-glycoprotein I protects thrombin from inhibition by heparin cofactor II: potentiation of this effect in the presence of anti-beta2-glycoprotein I autoantibodies.
Rahgozar S; Giannakopoulos B; Yan X; Wei J; Cheng Qi J; Gemmell R; Krilis SA
Arthritis Rheum; 2008 Apr; 58(4):1146-55. PubMed ID: 18383370
[TBL] [Abstract][Full Text] [Related]
2. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V.
Shi T; Giannakopoulos B; Yan X; Yu P; Berndt MC; Andrews RK; Rivera J; Iverson GM; Cockerill KA; Linnik MD; Krilis SA
Arthritis Rheum; 2006 Aug; 54(8):2558-67. PubMed ID: 16868978
[TBL] [Abstract][Full Text] [Related]
3. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
Yasuda S; Atsumi T; Ieko M; Koike T
Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
[TBL] [Abstract][Full Text] [Related]
4. Beta 2 glycoprotein I--function in health and disease.
Miyakis S; Giannakopoulos B; Krilis SA
Thromb Res; 2004; 114(5-6):335-46. PubMed ID: 15507263
[TBL] [Abstract][Full Text] [Related]
5. The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation.
Lean SY; Ellery P; Ivey L; Thom J; Oostryck R; Leahy M; Baker R; Adams M
Haematologica; 2006 Oct; 91(10):1360-6. PubMed ID: 17018385
[TBL] [Abstract][Full Text] [Related]
6. Beta2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis.
Horbach DA; van Oort E; Lisman T; Meijers JC; Derksen RH; de Groot PG
Thromb Haemost; 1999 Jan; 81(1):87-95. PubMed ID: 10348717
[TBL] [Abstract][Full Text] [Related]
7. Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.
Rahgozar S; Yang Q; Giannakopoulos B; Yan X; Miyakis S; Krilis SA
Arthritis Rheum; 2007 Feb; 56(2):605-13. PubMed ID: 17265495
[TBL] [Abstract][Full Text] [Related]
8. Anti-beta2-glycoprotein I antibodies recognizing platelet factor 4-heparin complex in antiphospholipid syndrome in patient substantiated with mouse model.
Bourhim M; Darnige L; Legallais C; Arvieux J; Cevallos R; Pouplard C; Vijayalakshmi MA
J Mol Recognit; 2003; 16(3):125-30. PubMed ID: 12833567
[TBL] [Abstract][Full Text] [Related]
9. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
Blank M; Krause I; Magrini L; Spina G; Kalil J; Jacobsen S; Thiesen HJ; Cunningham MW; Guilherme L; Shoenfeld Y
Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050
[TBL] [Abstract][Full Text] [Related]
10. Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies.
Ieko M; Ichikawa K; Triplett DA; Matsuura E; Atsumi T; Sawada K; Koike T
Arthritis Rheum; 1999 Jan; 42(1):167-74. PubMed ID: 9920027
[TBL] [Abstract][Full Text] [Related]
11. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases.
Lin WS; Chen PC; Yang CD; Cho E; Hahn BH; Grossman J; Hwang KK; Chen PP
Arthritis Rheum; 2007 May; 56(5):1638-47. PubMed ID: 17469158
[TBL] [Abstract][Full Text] [Related]
12. Beta-2 glycoprotein I and its role in antiphospholipid syndrome-lessons from knockout mice.
Miyakis S; Robertson SA; Krilis SA
Clin Immunol; 2004 Aug; 112(2):136-43. PubMed ID: 15240156
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
Pengo V; Bison E; Ruffatti A; Iliceto S
Thromb Res; 2008; 122(4):556-9. PubMed ID: 18328538
[TBL] [Abstract][Full Text] [Related]
14. A novel mechanism of thrombosis in antiphospholipid antibody syndrome.
Vlachoyiannopoulos PG; Routsias JG
J Autoimmun; 2010 Nov; 35(3):248-55. PubMed ID: 20638238
[TBL] [Abstract][Full Text] [Related]
15. Self-interaction of soluble and surface-bound beta2-glycoprotein I and its enhancement by lupus anticoagulants.
Hayashi A; Hayashi A; Matsuura E; Suzuki K; Koike T; Hashimoto E; Takeya H
FEBS Lett; 2008 Oct; 582(23-24):3308-12. PubMed ID: 18822289
[TBL] [Abstract][Full Text] [Related]
16. [Heparin cofactor II, a thrombin inhibitor with a still not clarified physiologic role].
Rossi EB; Duboscq CL; Kordich LC
Medicina (B Aires); 1999; 59(1):95-104. PubMed ID: 10349131
[TBL] [Abstract][Full Text] [Related]
17. Immunization of naive BALB/c mice with human beta2-glycoprotein I breaks tolerance to the murine molecule.
Tincani A; Gilburd B; Abu-Shakra M; Blank M; Allegri F; Ottaviani R; Riboni M; Meroni PL; Balestrieri G; Shoenfeld Y
Arthritis Rheum; 2002 May; 46(5):1399-404. PubMed ID: 12115248
[TBL] [Abstract][Full Text] [Related]
18. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.
Blank M; Krause I; Fridkin M; Keller N; Kopolovic J; Goldberg I; Tobar A; Shoenfeld Y
J Clin Invest; 2002 Mar; 109(6):797-804. PubMed ID: 11901188
[TBL] [Abstract][Full Text] [Related]
19. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation.
Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T
Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to beta2-glycoprotein I associated with antiphospholipid syndrome suppress the inhibitory activity of tissue factor pathway inhibitor.
Salemink I; Blezer R; Willems GM; Galli M; Bevers E; Lindhout T
Thromb Haemost; 2000 Oct; 84(4):653-6. PubMed ID: 11057865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
